Picture [LSG] – The Business Web Portal 600x80px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 1886 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Allergy Therapeutics plc. (9/28/17). "Press Release: Preliminary Results". 2017-09-28
NuCana plc. (9/28/17). "Press Release: NuCana plc Announces Pricing of Initial Public Offering". Edinburgh. 2017-09-28
Oxford Immunotec Global plc. (9/27/17). "Press Release: Oxford Immunotec Announces Update in Patent Infringement Litigation". Oxford & Marlborough, MA. 2017-09-27
Autolus Ltd.. (9/26/17). "Press Release: Autolus Secures US$80 Million Series C Funding". London. 2017-09-26
Bryan, Garnier & Co., Ltd.. (9/26/17). "Press Release: Wilson and Waanders Join London Healthcare Franchise as Managing Directors". London. 2017-09-26
Euformatics Oy. (9/26/17). "Press Release: Euformatics and Horizon Discovery Partner to Develop OncoMatic, a NGS Test Validation and QC Solution". 2017-09-26
Microsaic Systems plc. (9/25/17). "Press Release: Appointment of Chief Executive Officer". 2017-09-25
Abzena plc. (9/19/17). "Press Release: Abzena Appoints Lotta Ljungqvist as Non-Executive Director". Cambridge. 2017-09-19
Nabriva Therapeutics plc. (9/19/17). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million". Dublin & King of Prussia, PA. 2017-09-19
Hatteras Venture Partners. (9/19/17). "Press Release: Sir Andrew Witty Joins Hatteras Venture Partners". Durham, NC. 2017-09-19
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. 2017-09-18
Nabriva Therapeutics plc. (9/18/17). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King 2017-09-18
Autolus Ltd.. (9/18/17). "Press Release: Autolus Announces Initiation of the AMELIA and ALEXANDER Studies for AUTO3. Phase I/II Studies in Paediatric ALL and DLBCL". 2017-09-18
Autolus Ltd.. (9/18/17). "Press Release: Autolus Announces First-Dose Cohort Completed in APRIL Study of AUTO2. A Phase I/II Study in Patients with Multiple Myeloma". 2017-09-18
Bruker Corporation. (9/18/17). "Press Release: Bruker Launches the timsTOF Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics". Dublin. 2017-09-18
Immunocore Ltd.. (9/18/17). "Press Release: Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases". Oxford & Conshohocken, PA. 2017-09-18
Abzena plc. (9/14/17). "Press Release: Trading Update". Cambridge. 2017-09-14
Queen’s University Belfast. (9/14/17). "Press Release: Queen’s Launches Joint e-Learning Initiative with Waters Corporation to Tackle Food Fraud". 2017-09-14
Sophia Genetics S.A.. (9/13/17). "Press Release: Sophia Genetics Raises $30 Million in Series D Funding to Accelerate Its Mission of Democratizing Data-driven Medicine Worldwide". St. Sulpice. 2017-09-13
Genenta Science S.r.l.. (9/13/17). "Press Release: Genenta Raised Other $8,4 Million (€7 Million) in the Second Round of Financing - Total Raised in Two Rounds, $20,4 Million (€17 Million) -". Milano. 2017-09-13
BC Platforms. (9/13/17). "Press Release: BC Platforms Launches Unique Global Genomics and Clinical Data Analytics Resource". 2017-09-13
AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. 2017-09-13
AbCellera Biologics, Inc.. (9/12/17). "Press Release: AbCellera Launches Antibody Discovery Collaboration with GSK". Vancouver, BC. 2017-09-12
Centauri Therapeutics Ltd.. (9/11/17). "Press Release: Centauri Therapeutics Receives Innovate UK Biomedical Catalyst Award". London & Kent. 2017-09-11
TrakCel Ltd.. (9/11/17). "Press Release: Iovance Biotherapeutics Partners with TrakCel for Personalized Patient Product Management". San Carlos, CA. 2017-09-11
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. 2017-09-08
Illumina, Inc.. (9/7/17). "Press Release: Illumina Files New Patent Infringement Suit Against Premaitha Health plc". San Diego, CA. 2017-09-07
Adaptimmune Therapeutics plc. (9/7/17). "Press Release: GSK Exercises Option Over SPEAR T-cell Therapy Program Targeting NY-ESO". Philadeliphia, PA & Oxford. 2017-09-07
TrakCel Ltd.. (9/7/17). "Press Release: TrakCel Announces a Partnership Agreement to Incorporate Its Needle-to-Needle Supply Chain Management Platform into the CGT Catapult’s Large-scale Cell and Gene Therapy Manufacturing Centre". London. 2017-09-07
Markes International Ltd.. (9/7/17). "Press Release: Markes International Opens New Chinese Subsidiary in Shanghai". 2017-09-07
AB Sciex (d/b/a Sciex). (9/6/17). "Press Release: Sciex PA 800 Plus Continues to Deliver Quality Results for Ultimate Confidence in Biologics Characterization Data". Framingham, MA. 2017-09-06
Kiadis Pharma N.V.. (9/5/17). "Press Release: Kiadis Pharma Appoints Karl Hård as Head of Investor Relations and Communications". Amsterdam-Duivendrecht. 2017-09-05
Amal Therapeutics S.A.. (9/5/17). "Press Release: Amal Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round". Geneva. 2017-09-05
Global Antibiotic Research and Development Partnership (GARDP). (9/4/17). "Press Release: More than EUR 56 Million Raised to Fund Initiative to Fight Antibiotic Resistance". Berlin. 2017-09-04
Eurofins Scientific. (8/30/17). "Press Release: Eurofins Reports Solid H1 2017 Results with 15.6% Revenue Growth on the Back of an Organic growth of about 6% and over 35 Acquisitions". 2017-08-30
BioIndustry Assocation (BIA). (8/30/17). "Press Release: BIA Responds to Life Sciences Industrial Strategy". 2017-08-30
Carrick Therapeutics Ltd.. (8/30/17). "Press Release: Carrick Therapeutics Appoints Chairman as One of Two New Board Members". Dublin. 2017-08-30
Oxford Immunotec Global plc. (8/30/17). "Press Release: Oxford Immunotec Appoints Stefan Linn as Chief Operating Officer". Oxford & Marlborough, MA. 2017-08-30
LifeArc. (8/30/17). "Press Release: LifeArc and AUTM Forge International Partnership to Provide Training for Scholars in Technology Transfer". London & Gainesville, FL. 2017-08-30
Cell and Gene Therapy Catapult, The. (8/30/17). "Press Release: New Investment in Cell and Gene Therapy Catapult Manufacturing Centre". 2017-08-30
DBV Technologies S.A.. (8/29/17). "Press Release: DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut". Montrouge. 2017-08-29
Thermo Fisher Scientific Inc.. (8/29/17). "Press Release: Thermo Fisher Scientific Completes Acquisition of Patheon". Waltham, MA. 2017-08-29
AstraZeneca plc. (8/29/17). "Press Release: AstraZeneca and Takeda Establish Collaboration to Develop and Commercialise MEDI1341 for Parkinson’s Disease". 2017-08-29
Novartis AG. (8/24/17). "Press Release: Novartis Appoints Bertrand Bodson as Chief Digital Officer". Basel. 2017-08-24
BioAscent Discovery Ltd.. (8/23/17). "Press Release: Medivir Outsources Compound Management to BioAscent. Entire Library of 56,000 Samples Transferred in Under 3 Days". Newhouse. 2017-08-23
Macrophage Pharma Ltd.. (8/23/17). "Press Release: Macrophage Pharma Extends Series A Round to Include New Investor Merck Ventures". 2017-08-23
Orchard Therapeutics Ltd.. (8/22/17). "Press Release: Orchard Therapeutics Announces that OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency". London. 2017-08-22
Micro-Sphere S.A.. (8/22/17). "Press Release: CDMO to Invest €19m in GMP Facility Expansion". 2017-08-22
Ethris GmbH. (8/21/17). "Press Release: Ethris Enters Strategic Collaboration with AstraZeneca and MedImmune to Develop mRNA Therapies for Respiratory Diseases". Munich & Gaithersburg, MD. 2017-08-21
Oxford Genetics Ltd.. (8/21/17). "Press Release: Oxford Genetics Secures £7.5 Million Investment". 2017-08-21
AstraZeneca plc. (8/17/17). "Press Release: Lynparza Receives Additional and Broad Approval in the US for Ovarian Cancer". 2017-08-17
Concept Life Sciences Holdings Ltd.. (8/17/17). "Press Release: Concept Life Sciences Announces the Appointment of John Handley as Chief Operating Officer as the Company Prepares for the Next Stage of Growth and Development". 2017-08-17
Oxford BioMedica plc. (8/17/17). "Press Release: Interim Results for the Six Months Ended 30 June 2017". Oxford. 2017-08-17
Scott Partnership, The. (8/17/17). "Press Release (Blog): News from TSP. Louise Reid Has Been Promoted to Managing Director of The Scott Partnership Group". 2017-08-17
SpectralWorks Ltd.. (8/15/17). "Press Release: SpectralWorks and Mestrelab Research SL Announce Mutual Reseller Agreement". 2017-08-15
Cambridge Epigenetix Ltd.. (8/15/17). "Press Release: Cambridge Epigenetix and NuGen Technologies Sign Partnership Agreement to Combine Leading Technologies in Epigenetics Research". Cambridge. 2017-08-15
Mundipharma International Ltd.. (8/14/17). "Press Release: Mundipharma and CellAct Announce New Deal for the Worldwide Development and Commercialization of Smart Chemotherapy CAP7.1". 2017-08-14
Ionis Pharmaceuticals, Inc.. (8/11/17). "Press Release: Ionis to Independently Advance Inotersen and Ionis-FB-L Rx". Carlsbad, CA. 2017-08-11
Oxford BioMedica plc. (8/11/17). "Press Release: Oxford BioMedica Announces a £2 Million Two-year Collaboration Co-funded by Innovate UK". London. 2017-08-11
Evotec AG. (8/10/17). "Press Release: Evotec Announces First Half Year 2017 Results and Corporate Update". Hamburg. 2017-08-10
Orchard Therapeutics Ltd.. (8/10/17). "Press Release: Orchard Therapeutics Appoints Mark Rothera as CEO". London. 2017-08-10
Biotecnol Ltd.. (8/10/17). "Press Release: Biotecnol and CRUK to Trial New Immuno-oncology Treatment for Advanced Solid Tumours". 2017-08-10
Pieris Pharmaceuticals, Inc.. (8/9/17). "Press Release: Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2017 and Provides Corporate Update". Boston, MA. 2017-08-09
Galapagos N.V.. (8/9/17). "Press Release: GLPG1690 Halts Disease Progression in IPF Patients in FLORA Phase 2a Trial". Mechelen. 2017-08-09
Novo Nordisk A/S. (8/9/17). "Press Release: Novo Nordisk Increased Reported Operating Profit by 8% in the First Six Months of 2017". 2017-08-09
Oxford BioMedica plc. (8/7/17). "Press Release: Oxford BioMedica Announces MHRA Licence For Commercial Supply". London. 2017-08-07
Merck & Co., Inc.. (8/7/17). "Press Release: MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria. European Facility Will Boost Global Vaccine Production Capacity". Madison, NJ. 2017-08-07
Celyad S.A.. (8/4/17). "Press Release: Celyad Announces New Agreements with Celdara Medical and Dartmouth College". Mont-Saint-Guibert. 2017-08-04
Bristol-Myers Squibb Company. (8/3/17). "Press Relase: Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity". New York, NY & Boston, MA. 2017-08-03
Merck KGaA. (8/3/17). "Press Relase: European Patent Office to Grant Merck’s Patent Application for CRISPR Technology". Darmstadt. 2017-08-03
Genkyotex S.A.. (8/3/17). "Press Release: Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts". Archamps & Geneva. 2017-08-03
Sygnis AG. (8/3/17). "Press Release: Sygnis AG Reports Financial Results for the Second Quarter and First Six Months of 2017". Madrid & Heidelberg. 2017-08-03
AstraZeneca plc. (8/2/17). "Press Release: US FDA Accepts Regulatory Submission for Acalabrutinib and Grants Priority Review". 2017-08-02
TC BioPharm Ltd.. (8/2/17). "Press Release: TCB Selected for EU Horizon 2020 Funding to Progress Novel, Mass-market Cell Therapies to Clinical Trial". Scotland. 2017-08-02
Zyme Communications Ltd.. (8/1/17). "Press Relase: Zyme Communications Strengthens Team and Relocates Cambridge Office". Cambridge. 2017-08-01
AstraZeneca plc. (8/1/17). "Press Release: Acalabrutinib Granted Breakthrough Therapy Designation by US FDA for the Treatment of Patients with Mantle Cell Lymphoma". 2017-08-01
Horizon Discovery Group plc. (8/1/17). "Press Release: Horizon Discovery Announces Release of High Quality, Well Annotated CHO Genome Sequence to Drive Innovation in Bioproduction". Cambridge. 2017-08-01
Redx Pharma plc (in administration). (7/31/17). "Press Relase: Disposal of BTK Inhibitor Drug Development Program". 2017-07-31
Laboratory Corporation of America Holdings (LabCorp). (7/31/17). "Press Relase: LabCorp to Acquire Chiltern for approximately $1.2 Billion in Cash, Advancing Its Leadership in Drug Development". Burlington, NC, London & Wilmington, NC. 2017-07-31
AstraZeneca plc. (7/31/17). "Press Release: Imfinzi Granted Breakthrough Therapy Designation by US FDA for Patients with Locally-advanced Unresectable Non-small Cell Lung Cancer". 2017-07-31
Eurofins Scientific. (7/31/17). "Press Release: Eurofins Expands Its Offering and Footprint in Drug Discovery Services with the Acquisition of DiscoverX". 2017-07-31
Evotec AG. (7/30/17). "Press Release: Evotec to Acquire Aptuit, Expanding Leadership in External Innovation". Hamburg. 2017-07-30
Evotec AG. (7/27/17). "Press Release: Evotec Expands Collaboration with Storm Therapeutics on Its RNA Epigenetics Platform". Hamburg. 2017-07-27
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
AstraZeneca plc. (7/27/17). "Press Release: H1 2017 Results". 2017-07-27
AstraZeneca plc. (7/27/17). "Press Release: AstraZeneca and Merck Establish Strategic Oncology Collaboration". 2017-07-27
GlaxoSmithKline plc. (7/26/17). "Press Release: GSK Delivers Further Progress in Q2 and Sets Out New Priorities for the Group". London. 2017-07-26
XL-protein GmbH. (7/26/17). "Press Release: Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation Technology to Develop Long-Acting Asparaginase Product Candidates". Freising. 2017-07-26
GlaxoSmithKline plc. (7/25/17). "Press Release: Switching to a Dolutegravir Regimen from a Boosted Protease Inhibitor Regimen Maintained Viral Suppression and Improved Lipid Fractions in Patients with HIV and High Cardiovascular Risk". London. 2017-07-25
GlaxoSmithKline plc. (7/25/17). "Press Release: ViiV Healthcare Announces Superior Efficacy of Dolutegravir versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings". London. 2017-07-25
GlaxoSmithKline plc. (7/25/17). "Press Release: Karenann Terrell Appointed Chief Digital & Technology Officer, GSK". London. 2017-07-25
One Nucleus. (7/25/17). "Press Release: Instinctif Partners Becomes Latest Partner of One Nucleus". Cambridge. 2017-07-25
Protembis GmbH. (7/25/17). "Press Release: Protembis Initiates Collaboration with German Accelerator Life Sciences for Planned U.S. Expansion". Aachen & Cambridge, MA. 2017-07-25
Definiens AG. (7/24/17). "Press Release: Definiens Forearms Organization for Strategic Expansion". Munich. 2017-07-24
GlaxoSmithKline plc. (7/24/17). "Press Release: GSK Submits US Regulatory Filing of Arnuity Ellipta in Children with Asthma". 2017-07-24
GlaxoSmithKline plc. (7/24/17). "Press Release: Phase II Study Results Showed Comparable Viral Suppression Rates at 96 Weeks for a Two-drug Regimen of Long-acting Cabotegravir and Rilpivirine and a Three-drug Regimen in Patients with HIV". 2017-07-24
GlaxoSmithKline plc. (7/21/17). "Press Release: GSK Announces Board and Committee Changes". 2017-07-21
Novacyt S.A.. (7/20/17). "Press Release: Novacyt Revenues Half Year 2017". Paris & Cambridge. 2017-07-20
GlaxoSmithKline plc. (7/20/17). "Press Release: ViiV Healthcare Shares Data from Its Innovative Portfolio with HIV Community at IAS 2017". London. 2017-07-20
UK Biobank. (7/20/17). "Press Release: UK Biobank Makes Available Vast Trove of Genetics Information". 2017-07-20
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page


Picture [LSF] – The Business Web Portal 600x80px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px